Analysis of pharmacologic inhibitors of Jun N-terminal kinases.
Murray
B W
BW
Agouron Pharmaceuticals, San Diego, California 92121-1408, USA.
Bennett
B L
BL
Sasaki
D T
DT
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001483:Base Sequence; D002453:Cell Cycle; D017931:DNA Primers / Q000235:genetics; D004791:Enzyme Inhibitors / Q000032:analysis; D005434:Flow Cytometry; D015870:Gene Expression; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000235:genetics; D048031:JNK Mitogen-Activated Protein Kinases; D019169:Jurkat Cells; D007700:Kinetics; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D013379:Substrate Specificity; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology
D017931:DNA Primers; D004791:Enzyme Inhibitors; D007093:Imidazoles; D007376:Interleukin-2; D011725:Pyridines; D012333:RNA, Messenger; D011994:Recombinant Proteins; D000255:Adenosine Triphosphate; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases; C093642:SB 203580